US2020237792A1PendingUtilityA1

Palatinose for enhancing dietary supplement and pharmaceutical delivery

68
Individually held — no corporate assignee on recordPriority: Mar 19, 2005Filed: Feb 13, 2020Published: Jul 30, 2020
Est. expiryMar 19, 2025(expired)· nominal 20-yr term from priority
Inventors:Bruce W. Kneller
A61K 31/7076A61K 31/122A61K 31/70A61K 31/566A61K 31/197A61K 9/0019A61K 33/00A61K 38/05A61K 45/06A61K 31/7016
68
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention is directed to a dietary supplement comprising palatinose or a derivative thereof. The dietary supplement may be a nutritional product, a sports performance product, a weight loss product or a meal replacement product. The present invention is also directed to a method of increasing the absorption of a compound into the bloodstream, cells and tissue comprising administering palatinose, or a derivative thereof, in combination with the compound. The present invention also relates to a diluent for parenteral compounds. The diluent comprises palatinose or a derivative thereof. Another aspect of the present invention is directed to a method of decreasing the recovery time to pre-performance levels of total adenosine triphosphate (ATP) levels in a mammal comprising administering palatinose, or a derivative thereof, to the mammal. The present invention is further directed to a method of supplying a compound to a diabetic patient, burn victim patient or trauma victim patient. The method comprises administering palatinose, or a derivative thereof, in combination with the compound.

Claims

exact text as granted — not AI-modified
1 . A dietary supplement comprising isomaltulose and one or more compounds selected from the group consisting of epicatechin, epicatechin-3-gallate, epigallocatechin and epigallocatecin-3-gallate, wherein the concentration of isomaltulose is between about 10% and about 85%, and wherein the dietary supplement is in a form selected from the group consisting of a tablet, capsule, powder or drink. 
     
     
         2 . The dietary supplement of  claim 2 , wherein the dietary supplement is a nutritional product, a sports performance product, a weight loss product, or a meal replacement product. 
     
     
         3 . The dietary supplement of  claim 1 , wherein the concentration of isomaltulose is between about 10% and about 50%. 
     
     
         4 . The dietary supplement of  claim 1 , wherein the dietary supplement further comprises one or more of a sugar, a stimulant; creatine or a salt, ester or chelate thereof; carnitine or a salt, ester or chelate thereof; coenzyme Q-10; 7-keto-DHEA: a mineral; an undigestible bulk-forming starch; adenosine triphosphate; carbon dioxide; trehalose; amylose; glucose; a methylxanthine; amylopectin; calcium carbonate; sodium bicarbonate; glucuronolactone; sulbutiamine; fursultiamine; orotic acid; vinpocetine; rhodiola rosea; and cellulose. 
     
     
         5 . The dietary supplement of  claim 1 , wherein the dietary supplement comprises between about 0.5 grams and about 200 grams of isomaltulose. 
     
     
         6 . The dietary supplement of  claim 1 , wherein the compound comprises epicatechin. 
     
     
         7 . The dietary supplement of  claim 1 , wherein the compound comprises epigallocatechin. 
     
     
         8 . The dietary supplement of  claim 1 , wherein the compound comprises epicatechin-3-gallate. 
     
     
         9 . The dietary supplement of  claim 1 , wherein the compound comprises epigallocatecin-3-gallate. 
     
     
         10 . A method of increasing the absorption of a compound into the bloodstream of a mammal, wherein the method comprises administering to the mammal a composition comprising isomaltulose and one or more compounds selected from the group consisting of epicatechin, epicatechin-3-gallate, epigallocatechin and epigallocatecin-3-gallate. 
     
     
         11 . The method of  claim 10 , wherein the composition is selected from the group consisting of a dietary supplement, a nutrient or a pharmaceutical. 
     
     
         12 . The method of  claim 10 , wherein the composition is in a form selected from the group consisting of a tablet, capsule, powder or drink. 
     
     
         13 . The method of  claim 10 , wherein the concentration of isomaltulose in the composition is between about 10% and about 85%. 
     
     
         14 . The method of  claim 10 , wherein the concentration of isomaltulose in the composition is between about 10% and about 50%. 
     
     
         15 . The method of  claim 10 , wherein the composition comprises between about 0.5 grams and about 200 grams of isomaltulose. 
     
     
         16 . The method of  claim 10 , wherein the composition further comprises one or more of a sugar; a stimulant; creatine or a salt, ester or chelate thereof; carnitine or a salt, ester or chelate thereof; coenzyme Q-10; 7-keto-DHEA; a mineral; an undigestible bulk-forming starch; adenosine triphosphate; carbon dioxide; trehalose; amylose; glucose; a methylxanthine; amylopectin; calcium carbonate; sodium bicarbonate; glucuronolactone; sulbutiamine; fursultiamine; orotic acid; vinpocetine; rhodiola rosea; and cellulose. 
     
     
         17 . The method of  claim 10 , wherein the compound comprises epicatechin. 
     
     
         18 . The method of  claim 10 , wherein the compound comprises epicatechin-3-gallate. 
     
     
         19 . The method of  claim 10 , wherein the compound comprises epigallocatechin. 
     
     
         20 . The method of  claim 10 , wherein the compound comprises epigallocatecin-3-gallate. 
     
     
         21 - 31 . (canceled)

Join the waitlist — get patent alerts

Track US2020237792A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.